3 x
NAG:
2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.1:
3
residues within 4Å:
Chain A:
H.74,
N.75,
T.77
1 PLIP interactions:
1 interactions with chain A
Hydrogen bonds:
A:N.75
NAG.3:
3
residues within 4Å:
Chain B:
H.74,
N.75,
T.77
1 PLIP interactions:
1 interactions with chain B
Hydrogen bonds:
B:N.75
NAG.5:
3
residues within 4Å:
Chain C:
H.74,
N.75,
T.77
1 PLIP interactions:
1 interactions with chain C
Hydrogen bonds:
C:N.75
3 x
R31:
(2S,4S,5S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-6-{4-[2-(3-methoxypropoxy)phenyl]-3-oxopiperazin-1-yl}-2-(propan-2-yl)hexanamide(Non-covalent)
Nakamura, Y. et al., Design and optimization of novel (2S,4S,5S)-5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxy-2-isopropylhexanamides as renin inhibitors. Bioorg.Med.Chem.Lett. (2012)